术前系统治疗指南.ppt
《术前系统治疗指南.ppt》由会员分享,可在线阅读,更多相关《术前系统治疗指南.ppt(18页珍藏版)》请在三一文库上搜索。
1、NCCN Guidelines Version 3.2014 Preoperative Systemic Therapy Guideline of breast-conserving therapy Absolute: Radiation therapy during pregnancy(注:邻近分娩时,可先期 手术,将放射治疗延迟至分娩以后时才考虑保乳 ) Diffuse suspicious or malignant-appearing microcalcifications (弥漫可疑/癌性微钙化灶) Widespread disease that cannot be incorpora
2、ted by local excision through a single incision that achieves negative margins with a satisfactory cosmetic result(注:多灶、多中心 为禁忌) Positive pathologic margin Contraindications for breast- conserving therapy requiring radiation therapy include: Relative: Prior radiation therapy to the chest wall or bre
3、ast Active connective tissue disease involving the skin (especially scleroderma and lupus (注:因不能耐受放疗,可能导致严重的 纤维化和软组织或骨的坏死) Tumors 5 cm (category 2B) Focally positive margin(注:显微镜下不伴有广泛导管内癌成分的 局灶性阳性切缘可选择性保乳,更高剂量的瘤床推照) Women with a known or suspected genetic predisposition to breast cancer: 1)May have
4、 an increased risk of ipsilateral breast recurrence(患侧复发) or contralateral(对侧) breast cancer with breast-conserving therapy 2)Prophylactic bilateral mastectomy for risk reduction may be considered(预防性双乳切除). Contraindications for breast- conserving therapy requiring radiation therapy include: Stage I
5、IA T2, N0, M0 Stage IIB T2, N1, M0;T3, N0, M0 Stage lllA T3, N1, M0 Fulfills criteria for breast-conserving surgery except for tumor size CLINICAL STAGE History and physical exam CBC, platelets Liver function tests and alkaline phosphatase Bilateral mammogram(双乳X线); Ultrasound Pathology review Tumor
6、 ER/PR status and HER2 status Genetic counseling if patient is high risk for hereditary(遗传) breast cancer Breast MRI (optional), with special consideration for mammographically occult(钼靶隐匿) tumors Fertility counseling if premenopausal(绝经前) Consider systemic staging (particularly if signs and symptom
7、s are present): Chest diagnostic CT Abdominal(腹) pelvic(盆) diagnostic CT or MRI Bone scan or sodium fluoride(氟化钠:主评骨) PET/CT (category 2B) FDG PET/CT (optional, category 2B) WORKUP Desires breast preservation: Core biopsy with placement of image-detectable marker(s), if not previously performed, mus
8、t be done to demarcate the tumor bed for post-chemotherapy surgical management. 即:术前需行瘤床定位 Does not desire breast preservation:See Locoregional(局部) Treatment of Clinical Stage I, IlA, or IlB Disease or T3, N1, M0. Preoperative Systemic Therapy Breast and Axillary Evaluation Clinically negative : sho
9、uld have axillary ultrasound ; suspicious nodes should be sampled by FNA or core biopsy and clipped with image- detectable marker; positive clipped lymph nodes must be removed if FNA or core biopsy was positive prior to neoadjuvant therapy. Clinically positive:should be sampled by FNA or core biopsy
10、 and clipped with image-detectable marker; positive clipped lymph nodes must be removed if FNA or core biopsy was positive prior to neoadjuvant therapy. 简言之,淋巴结怀疑阳性的需活检取样,若证实,在新 辅助治疗前切除。 Axillary lymph node(s) Preoperative systemic therapy Endocrine therapy alone may be considered for receptor- posi
- 配套讲稿:
如PPT文件的首页显示word图标,表示该PPT已包含配套word讲稿。双击word图标可打开word文档。
- 特殊限制:
部分文档作品中含有的国旗、国徽等图片,仅作为作品整体效果示例展示,禁止商用。设计者仅对作品中独创性部分享有著作权。
- 关 键 词:
- 系统 治疗 指南
链接地址:https://www.31doc.com/p-3343223.html